表紙
市場調查報告書

妥瑞症(TS) - 全球臨床試驗檢討:2020年前期

Tourette Syndrome Global Clinical Trials Review, H1, 2020

出版商 GlobalData 商品編碼 955993
出版日期 內容資訊 英文
訂單完成後即時交付
價格
妥瑞症(TS) - 全球臨床試驗檢討:2020年前期 Tourette Syndrome Global Clinical Trials Review, H1, 2020
出版日期: 2020年06月15日內容資訊: 英文
簡介

本報告提供妥瑞症(TS)臨床試驗相關的主要資料,提供實驗數及其全球主要各國所進行的平均登記數,地區,國家(G7及E7),實驗階段,實驗現狀,端點現狀,各贊助商類型的疾病臨床試驗範圍,再加上進行中的實驗上有潛力的藥劑等相關資訊。

目錄

表格的清單

圖的清單

  • 報告指南
  • GlobalData臨床試驗報告的涵蓋範圍
  • 臨床試驗:各地區
  • 臨床試驗與平均登記數:各國
  • 亞太地區為臨床試驗做出貢獻的前五名國家
  • 歐洲為臨床試驗做出貢獻的前五名國家
  • 北美為臨床試驗做出貢獻的前幾名國家
  • 中東·非洲為臨床試驗做出貢獻的前五名國家
  • 中南美為臨床試驗做出貢獻的前五名國家
  • G7各國的臨床試驗:中樞神經系統臨床試驗上妥瑞症 (TS)的比例
  • G7各國的臨床試驗:不同階段
  • G7各國的臨床試驗:各實驗狀態
  • E7各國的臨床試驗:中樞神經系統臨床試驗上妥瑞症 (TS)的比例
  • E7各國的臨床試驗:不同階段
  • E7各國的臨床試驗:各實驗狀態
  • 臨床試驗:不同階段
  • 進行中的臨床試驗:不同階段
  • 臨床試驗:各實驗狀態
  • 臨床試驗:各端點狀態
  • 一定期間所募集的實驗對象
  • 臨床試驗:各贊助商類型
  • 有潛力的贊助商
  • 參加妥瑞症 (TS) 治療的臨床試驗的前幾名企業
  • 有前途的醫藥品
  • 臨床試驗簡介的概述

附錄

  • 簡稱
  • 定義
  • 調查手法
  • 2次調查
  • 關於GlobalData
  • 諮詢方式
  • 來源
目錄
Product Code: GDHC6287CTIDB

GlobalData's clinical trial report, "Tourette Syndrome Global Clinical Trials Review, H1, 2020" provides an overview of Tourette Syndrome Clinical trials scenario. This report provides top line data relating to the clinical trials on Tourette Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

List of Tables

List of Figures

  • Report Guidance
  • GlobalData Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Tourette Syndrome to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Tourette Syndrome to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Tourette Syndrome Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots

Appendix

  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About GlobalData
  • Contact Us
  • Source

List of Tables

List of Tables

  • Tourette Syndrome Therapeutics, Global, Clinical Trials by Region, 2020*
  • Tourette Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Tourette Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries, 2020*
  • Proportion of Tourette Syndrome to Central Nervous System Clinical Trials, G7 Countries (%), 2020*
  • Tourette Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
  • Tourette Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
  • Proportion of Tourette Syndrome to Central Nervous System Clinical Trials, E7 Countries (%), 2020*
  • Tourette Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
  • Tourette Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
  • Tourette Syndrome Therapeutics, Global, Clinical Trials by Phase, 2020*
  • Tourette Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2020*
  • Tourette Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
  • Tourette Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*

List of Figures

List of Figures

  • Tourette Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2020*
  • Tourette Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Tourette Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2020*
  • Proportion of Tourette Syndrome to Central Nervous System Clinical Trials, G7 Countries (%), 2020*
  • Tourette Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
  • Tourette Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
  • Proportion of Tourette Syndrome to Central Nervous System Clinical Trials, E7 Countries (%), 2020*
  • Tourette Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
  • Tourette Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
  • Tourette Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2020*
  • Tourette Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2020*
  • Tourette Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
  • Tourette Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*
  • GlobalData Methodology